Antibiotics Use and Antimicrobial Stewardship
A section of Antibiotics (ISSN 2079-6382).
Section Information
Resistance to antibiotics is one of the main barriers to manage patients with bacterial infections worldwide, and the threat is increasing. It is well known that the inappropriate use of antibiotics at different levels is probably the driving source of resistance. This idea prompted the “One Health” concept some years ago.
We welcome studies describing how antibiotics are being prescribed, dispensed, administered or used in the real world, even how their waste is managed. This research helps identify points along the value and consumption chains that could be the basis for designing interventions to modify the current situation.
At the same time, we must learn from successful antibiotic stewardship experiences, especially those that go beyond hospital care and those testing innovative approaches which help to really modify behaviours and help change the global antibiotic resistance panorama.Editorial Board
Topic Board
Special Issues
Following special issues within this section are currently open for submissions:
- Pediatric Antimicrobial Stewardship (Deadline: 30 September 2021)
- Artificial Intelligence and Machine Learning Techniques for Epidemiology, Diagnostic and Treatment of Infectious Diseases (Deadline: 30 September 2021)
- Difficult to Treat Infections in Urology (Deadline: 30 September 2021)
- Antibiotics and Antibiotic Resistance in Aquatic Environments (Deadline: 30 September 2021)
- Appropriateness of Antibiotics in China (Deadline: 30 September 2021)
- The Effects of Antibiotics and Various Other Drugs on Gastrointestinal Microbiota: Roles in Health and Disease (Deadline: 30 September 2021)
- Implications of Antibiotics Use during the COVID-19 Pandemic: Present and Future (Deadline: 30 September 2021)
- Multi-Drug Resistant Gram-Negative Infections: Molecular Epidemiology, Microbiological Diagnosis and Antimicrobial Treatment (Deadline: 31 October 2021)
- The Possible Role of Antibiotic-Modified Microbiome in the Development and Proliferation of Non-Communicable Diseases (Deadline: 31 October 2021)
- Antimicrobials and Diabetes: Role in Onset and/or Treatment (Deadline: 31 October 2021)
- Antibiotic Treatment of Oral Infections (Deadline: 31 October 2021)
- Trends in Antibiotic Resistance in the Hospital Setting and Its Impact on Public Health (Deadline: 31 October 2021)
- Antibiotics Use in Primary Care during COVID-19 (Deadline: 31 October 2021)
- Antibiotic Tolerance in Pseudomonas aeruginosa (Deadline: 31 October 2021)
- The Optimization of Antimicrobial Prescribing and Stewardship (Deadline: 15 November 2021)
- Ocular Surface Infection and Antimicrobials (Deadline: 30 November 2021)
- Antibiotic Use in the Communities (Deadline: 30 November 2021)
- Optimization and Improvement of Veterinary Antimicrobial Treatment to Reduce Antimicrobial Resistance (Deadline: 30 November 2021)
- Antibiotics: Reconciling Profit and Sustainable Use (Deadline: 30 November 2021)
- Treatment of Mastitis in Dairy Cattle (Deadline: 30 November 2021)
- Antibiotic Prophylaxis for Surgical Site Infection in General Surgery (Deadline: 30 November 2021)
- Antimicrobial-Resistant Pathogens Isolated from Animals and Their Products (Deadline: 30 November 2021)
- Antimicrobial Material in Dentistry (Deadline: 30 November 2021)
- Antimicrobial Use and Stewardship during the COVID-19 Era (Deadline: 15 December 2021)
- Key Collaborations between Antimicrobial Stewardship & Clinical Microbiology – Focus on Diagnostic Stewardship (Deadline: 15 December 2021)
- Monitoring and Surveillance of Veterinary Antimicrobial Use and Antibiotic Resistance in Animals (Deadline: 31 December 2021)
- Biofilm-Associated Vaginal Infections (Deadline: 31 December 2021)
- Access, Consumption and Use of Antimicrobials (Deadline: 31 December 2021)
- Bacterial Contamination and Nano-Technological Solutions in Industry (Deadline: 31 December 2021)
- Surveillance for Antimicrobial Resistance and Healthcare-Associated Infections in Hospital (Deadline: 31 December 2021)
- Antimicrobial Stewardship and Infection Control (Deadline: 31 December 2021)
- Antimicrobial Prescribing and Stewardship, 2nd Volume (Deadline: 31 December 2021)
- Impact of Pandemic of COVID-19 on Antibiotic Prescription/Sales and on Antibiotic Resistances (Deadline: 31 December 2021)
- Antimicrobial Agents Used in Intensive Care Unit (Deadline: 31 December 2021)
- Colistin Resistance: The Need for a One Health Approach (Deadline: 31 December 2021)
- Alternative Approaches to Treating Antimicrobial Resistant Infections (Deadline: 31 December 2021)
- Severe Infections Due to Carbapenem-resistant Pathogens (Deadline: 31 December 2021)
- Combating Antifungal-Resistant and -Tolerant Fungi in the Clinic (Deadline: 31 December 2021)
- Antimicrobial Use, Resistance and Stewardship (Deadline: 31 December 2021)
- Antibiotic Therapy in Prosthetic Joint Infections (Deadline: 31 December 2021)
- Antibiotic Use in Clinical Infection: How to Reinvent Old Molecules and How to Squeeze Out New Ones (Deadline: 31 January 2022)
- Fracture-Related Infection: An Update on Antimicrobial Therapy (Deadline: 31 January 2022)
- Interventions to Reduce Antimicrobial Resistance in Low and Middle-Income Countries (Deadline: 31 January 2022)
- Infection Control and Antibiotic Use in Hospital (Deadline: 28 February 2022)
- Antimicrobial Stewardship in Livestock (Deadline: 28 February 2022)
- Social Dimensions of Antibiotic Resistance in Asia - a One Health Perspective (Deadline: 28 February 2022)
- Combination Therapy against Multidrug-Resistant Pathogens (Deadline: 1 March 2022)
- Antibiotics Use and Stewardship in China (Deadline: 18 March 2022)
- Risk of Recurrence and Risk Reduction Strategies of Implant-related Bone and Joint Infections (Deadline: 31 March 2022)
- Understanding the Antimicrobial Smart Use: Community Pharmacists’ Perspectives and Practices (Deadline: 30 April 2022)
- Antibiotic Use in Veterinary (Deadline: 30 April 2022)
